Extended-release naltrexone initiated after just five to seven days of seeking treatment is more effective than starting treatment after the traditional interim stage of 10 to 15 days.
Study finds that postpartum depression is underdiagnosed in those reporting symptoms up to a year after giving birth, with Black and Asian individuals least likely to receive treatment.
Columbia psychologist Erin K. Engle discusses the signs that indicate the time is right to stop therapy and questions patients should ask themselves before moving on.
An event from the Department of Psychiatry and School of Journalism explored the state of mental health in America’s children, adolescents, and young adults.
The post-COVID Community Mental Health Project aims to promote wellness and increase access to behavioral health services in underserved New York City neighborhoods.
A significant level of symptoms of depression, anxiety, and post-traumatic stress may follow COVID-19 independent of any previous psychiatric diagnoses, a new Mailman study finds.
Primary care physicians can help women deal with anxiety and depression, which are on the rise even as COVID cases decline, says Columbia physician Dr. Arthi Reddy.
A Columbia neuroscientist and psychiatrist is peering into brain cells for clues that may explain how COVID-19 can lead to depression, anxiety, psychosis, and suicide.
Specialized psychosocial interventions—including meaning-centered psychotherapy—can greatly improve a cancer patient's quality of life and reduce suffering.
In children with certain autism mutations, the diversity and severity of symptoms are often related to the identity and properties of gene units, called exons, targeted by the mutations.